Table of Contents
1 Table Of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 12
2.1 What Is This Report About? 12
3 Definitions of
Markets Covered in the Report 13
3.1 Ophthalmic Devices 13
3.2
Cataract Surgery 13
3.2.1 Phacoemulsification Equipment 13
3.2.2 Intra
Ocular Lens 13
3.3 Vision Care 13
3.3.1 Ophthalmoscopes 13
3.3.2
Contact lenses 13
3.3.3 Lens care 13
3.3.4 Ophthalmic lens 14
3.3.5 Rigid Gas Permeable Contact Lenses 14
3.4 Refractive Surgery 14
4 Healthcare Sector Review 15
4.1 Healthcare Expenditure 15
4.2
Healthcare Infrastructure 18
4.3 Healthcare Policy 20
4.3.1 Health
Insurance Act 21
4.3.2 Healthcare Allowance Act 21
4.3.3 The
Exceptional Medical Expenses Act 21
5 Regulation System 22
5.1 Medical
Equipment Approval Process 22
5.1.1 Classification of Medical Devices
22
5.1.2 Conformity Assessment Process 32
5.1.2.1 Class I devices
32
5.1.2.2 Class IIa devices 33
5.1.2.3 Class IIb devices 34
5.1.2.4 Class III devices 35
5.2 Post Market Surveillance (PMS) 35
6
Pricing and Reimbursement 36
6.1 Pricing and Reimbursement in Netherlands
36
7 Distribution Structure 37
7.1 Distribution Structure in
Netherlands 37
8 Ophthalmic Devices In Netherlands 38
8.1 Ophthalmic
Devices Cross Country Comparison (2000-2012) 38
8.2 Ophthalmic Devices,
Netherlands, Overall Revenues ($ mn), 2000-2012 39
8.3 Ophthalmic Devices,
Netherlands, Category Volume (Units), 2000-2012 43
8.4 Ophthalmic Devices,
Netherlands Company share (2006-2007) 44
9 Cataract Surgery In Netherlands
45
9.1 Cataract Surgery Overall Revenue (2000-2012) 45
9.2 Cataract
Surgery Overall Volume (2000-2012) 47
9.3 Cataract Surgery Average Price
(2000-2012) 49
9.4 Cataract Surgery Distribution Share (2006-2007) 50
9.5 Cataract Surgery, Netherlands, Company Share (2006-2007) 51
10
Refractive Surgery In Netherlands 52
10.1 Refractive Surgery Overall
Revenue (2000-2012) 52
10.2 Refractive Surgery Overall Volume (2000-2012)
54
10.3 Refractive Surgery Average Price (2000-2012) 56
10.4
Refractive Surgery Distribution Share (2006-2007) 57
10.5 Refractive
Surgery, Netherlands, Company Share (2006-2007) 58
11 Vision Care In
Netherlands 59
11.1 Vision Care Overall Revenue (2000-2012) 59
11.2
Vision Care Overall Volume (2000-2012) 61
11.3 Vision Care Average Price
(2000-2012) 63
11.4 Vision Care Distribution Share (2006-2007) 64
11.5
Vision Care, Netherlands, Company Share (2006-2007) 65
12 Bausch & Lomb
Incorporated Company Profile 66
12.1 Company Overview 66
12.2 Value
Chain Analysis 67
12.2.1 Manufacturing 67
12.2.1.1 In House
Manufacturing 67
12.2.1.2 Outsourcing 67
12.2.2 Product Development
67
12.2.2.1 Clinical Trials 67
12.2.2.2 Regulatory Approvals 68
12.2.2.3 Research and Development 68
12.2.3 Sales and Marketing 69
12.2.3.1 E-distribution 69
12.2.3.2 Partnerships and Alliances 69
12.2.3.3 Licensing Agreements 69
12.3 Bausch & Lomb Incorporated Pipeline
Products 69
12.3.1 Bausch & Lomb Incorporated Pipeline Products By
Equipment Type 69
12.3.2 Bausch & Lomb Incorporated Pipeline Products By
Development Stage 69
12.3.3 Bausch & Lomb Incorporated Pipeline Products
By Therapy Area 70
12.3.4 Bausch & Lomb Incorporated Pipeline Products By
Clinical Trials 70
12.3.5 Bausch & Lomb Incorporated Pipeline Products By
News Summary 70
13 Johnson & Johnson Vision Care, Inc. Company Profile
71
13.1 Company Overview 71
14 Alcon, Inc. Company Profile 72
14.1
Company Overview 72
14.2 Value Chain Analysis 73
14.2.1 Manufacturing
73
14.2.1.1 In House Manufacturing 73
14.2.1.2 Outsourcing 73
14.2.2 Product Development 73
14.2.2.1 Research and Development 73
14.2.2.2 Regulatory Approvals 74
14.2.2.3 Clinical Trials 74
14.2.3
Sales and Marketing 75
14.2.3.1 Licensing Agreements 75
14.2.3.2
Partnerships and Alliances 75
14.3 Alcon, Inc. Pipeline Products 75
14.3.1 Alcon, Inc. Pipeline Products By Equipment Type 75
14.3.2 Alcon,
Inc. Pipeline Products By Development Stage 76
14.3.3 Alcon, Inc. Pipeline
Products By Therapy Area 76
14.3.4 Alcon, Inc. Pipeline Products By
Clinical Trials 76
14.3.5 Alcon, Inc. Pipeline Products By News Summary
76
15 Essilor International Company Profile 77
15.1 Company Overview
77
15.2 Value Chain Analysis 78
15.2.1 Manufacturing 78
15.2.1.1
In House Manufacturing 78
15.2.2 Product Development 78
15.2.2.1
Regulatory Approvals 78
15.2.2.2 Research and Development 79
15.2.3
Sales and Marketing 79
15.2.3.1 Partnerships and Alliances 79
16 CIBA
Vision Corporation Company Profile 80
16.1 Company Overview 80
16.2
CIBA Vision Corporation Pipeline Products 80
16.2.1 CIBA Vision
Corporation Pipeline Products By Equipment Type 80
16.2.2 CIBA Vision
Corporation Pipeline Products By Development Stage 80
16.2.3 CIBA Vision
Corporation Pipeline Products By Therapy Area 80
16.2.4 CIBA Vision
Corporation Pipeline Products By Clinical Trials 80
17 CooperVision, Inc.
Company Profile 81
17.1 Company Overview 81
17.2 Cooper Vision, Inc.
Pipeline Products 81
17.2.1 Cooper Vision, Inc. Pipeline Products By
Equipment Type 81
17.2.2 Cooper Vision, Inc. Pipeline Products By
Development Stage 81
17.2.3 Cooper Vision, Inc. Pipeline Products By
Therapy Area 82
18 AkkoLens International BV Company Profile 83
18.1
Company Overview 83
18.2 AkkoLens International BV Pipeline Products
83
18.2.1 AkkoLens International BV Pipeline Products By Equipment Type
83
18.2.2 AkkoLens International BV Pipeline Products By Development Stage
83
18.2.3 AkkoLens International BV Pipeline Products By Therapy Area
83
19 Eye4Vision Ophthalmics Int' l. Company Profile 84
19.1 Company
Overview 84
19.2 Eye4Vision Ophthalmics Int' l. Pipeline Products 84
19.2.1 Eye4Vision Ophthalmics Int' l. Pipeline Products By Equipment Type
84
19.2.2 Eye4Vision Ophthalmics Int' l. Pipeline Products By Development
Stage 84
19.2.3 Eye4Vision Ophthalmics Int' l. Pipeline Products By Therapy
Area 84
20 OPHTEC BV Company Profile 85
20.1 Company Overview 85
20.2 OPHTEC BV Pipeline Products 85
20.2.1 OPHTEC BV Pipeline Products By
Equipment Type 85
20.2.2 OPHTEC BV Pipeline Products By Development Stage
85
20.2.3 OPHTEC BV Pipeline Products By Therapy Area 85
20.2.4 OPHTEC
BV Pipeline Products By Clinical Trials 85
20.2.5 OPHTEC BV Pipeline
Products By News Summary 85
21 APPENDIX 86
21.1 Global Markets Direct
Research Methodology 86
21.2 Coverage 87
21.3 Secondary Research
87
21.4 Primary Research 88
21.5 Models 88
21.6 Forecasts 89
21.7 Expert Panels 89
21.8 Currency Conversion 90
21.9 Contact Us
91
21.10 Disclaimer 91
1.1 List of Tables
Table 1: Doctors by
Specialty in Netherlands, 2000-2006 19
Table 2: Hospital Wards by Type in
Netherlands, 2000-2006 20
Table 3: Ophthalmic Devices Cross Country
Comparison (2000-2012) 38
Table 4: Ophthalmic Devices, Netherlands,
Overall Revenues ($ mn), 2000-2012 39
Table 5: Ophthalmic Devices
Market, Netherlands, Portfolio Analysis, 2000-2012 40
Table 6:
Ophthalmic Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
41
Table 7: Ophthalmic Devices, Netherlands, Overall Revenues ($ mn),
Forecast, 2007-2012 42
Table 8: Ophthalmic Devices, Netherlands,
Category Volume (Units), 2000-2012 43
Table 9: Ophthalmic Devices,
Netherlands, Category Volume (Units), Historic, 2000-2007 43
Table 10:
Ophthalmic Devices, Netherlands, Category Volume (Units), Forecast, 2007-2012
43
Table 11: Ophthalmic Devices, Netherlands Company share by Revenue
($ mn), 2006-2007 44
Table 12: Cataract Surgery, Netherlands, Revenue
($ mn) by Segment, Historic, 2000-2007 45
Table 13: Cataract Surgery,
Netherlands, Revenue ($ mn) by Segment, Forecast, 2007-2012 46
Table 14:
Cataract Surgery, Netherlands, Overall Volume (Units), Historic, 2000-2007
47
Table 15: Cataract Surgery, Netherlands, Overall Volume (Units),
Forecast, 2007-2012 48
Table 16: Cataract Surgery, Netherlands,
Average Price ($), Historic, 2000-2007 49
Table 17: Cataract Surgery,
Netherlands, Average Price ($), Forecast, 2007-2012 49
Table 18:
Cataract Surgery, Netherlands, Distribution Share by Revenue ($mn), 2006-2007
50
Table 19: Cataract Surgery, Netherlands, Company Share by Revenue
($ mn), 2006-2007 51
Table 20: Refractive Surgery, Netherlands,
Revenue ($ mn), Historic, 2000-2007 52
Table 21: Refractive Surgery,
Netherlands, Revenue ($ mn), Forecast, 2007-2012 53
Table 22:
Refractive Surgery, Netherlands, Overall Volume (Units), Historic, 2000-2007
54
Table 23: Refractive Surgery, Netherlands, Overall Volume (Units),
Forecast, 2007-2012 55
Table 24: Refractive Surgery, Netherlands,
Average Price ($), Historic, 2000-2007 56
Table 25: Refractive
Surgery, Netherlands, Average Price ($), Forecast, 2007-2012 56
Table 26:
Refractive Surgery, Netherlands, Distribution Share by Revenue ($mn),
2006-2007 57
Table 27: Refractive Surgery, Netherlands, Company Share
by Revenue ($ mn), 2006-2007 58
Table 28: Vision Care, Netherlands,
Revenue ($ mn) by Segment, Historic, 2000-2007 59
Table 29: Vision
Care, Netherlands, Revenue ($ mn) by Segment, Forecast, 2007-2012 60
Table
30: Vision Care, Netherlands, Overall Volume (Units), Historic, 2000-2007
61
Table 31: Vision Care, Netherlands, Overall Volume (Units),
Forecast, 2007-2012 62
Table 32: Vision Care, Netherlands, Average
Price ($), Historic, 2000-2007 63
Table 33: Vision Care, Netherlands,
Average Price ($), Forecast, 2007-2012 63
Table 34: Vision Care,
Netherlands, Distribution Share by Revenue ($mn), 2006-2007 64
Table 35:
Vision Care, Netherlands, Company Share by Revenue ($ mn), 2006-2007 65
Table 36: Bausch & Lomb Incorporated Pipeline Products by Equipment Type
69
Table 37: Bausch & Lomb Incorporated Pipeline Products By
Development Stage 69
Table 38: Bausch & Lomb Incorporated Pipeline
Products By Therapy Area 70
Table 39: Bausch & Lomb Incorporated
Pipeline Products By Clinical Trials 70
Table 40: Bausch & Lomb
Incorporated Pipeline Products By News Summaries 70
Table 41: Alcon,
Inc. Pipeline Products by Equipment Type 75
Table 42: Alcon, Inc.
Pipeline Products By Development Stage 76
Table 43: Alcon, Inc.
Pipeline Products By Therapy Area 76
Table 44: Alcon, Inc. Pipeline
Products By Clinical Trials 76
Table 45: Alcon, Inc. Pipeline
Products By News Summaries 76
Table 46: CIBA Vision Corporation
Pipeline Products by Equipment Type 80
Table 47: CIBA Vision
Corporation Pipeline Products by Development Stage 80
Table 48: CIBA
Vision Corporation Pipeline Products By Therapy Area 80
Table 49:
CIBA Vision Corporation Pipeline Products By Clinical Trials 80
Table 50:
Cooper Vision, Inc. Pipeline Products by Equipment Type 81
Table 51:
Cooper Vision, Inc. Pipeline Products By Development Stage 81
Table 52:
Cooper Vision, Inc. Pipeline Products By Therapy Area 82
Table 53:
AkkoLens International BV Pipeline Products by Equipment Type 83
Table
54: AkkoLens International BV Pipeline Products By Development Stage
83
Table 55: AkkoLens International BV Pipeline Products By Therapy
Area 83
Table 56: Eye4Vision Ophthalmics Int' l. Pipeline Products by
Equipment Type 84
Table 57: Eye4Vision Ophthalmics Int' l. Pipeline
Products by Development Stage 84
Table 58: Eye4Vision Ophthalmics
Int' l. Pipeline Products By Therapy Area 84
Table 59: OPHTEC BV
Pipeline Products by Equipment Type 85
Table 60: OPHTEC BV Pipeline
Products by Development Stage 85
Table 61: OPHTEC BV Pipeline
Products By Therapy Area 85
Table 62: OPHTEC BV Pipeline Products By
Clinical Trials 85
Table 63: OPHTEC BV Pipeline Products By News
Summaries 85
Table 64: Currency Conversion from USD to Local Currency at
2007 Constant Rate 90
1.2 List of Figures
Figure 1: Total
Healthcare Expenditure in Netherlands, 2000 - 2006 16
Figure 2: Healthcare
Financing Framework in Netherlands, 2005 17
Figure 3: Flowchart for
Classification of Non-invasive Devices in Netherlands, 2007 24
Figure 4:
Flowchart for Classification of Invasive Devices in Netherlands, 2007 25
Figure 5: Flowchart for Classification of Invasive Devices in Netherlands,
2007 26
Figure 6: Flowchart for Classification of Invasive Devices in
Netherlands, 2007 27
Figure 7: Flowchart for Classification of Invasive
Devices in Netherlands, 2007 28
Figure 8: Flowchart for Classification of
Active Devices in Netherlands, 2007 29
Figure 9: Flowchart for
Classification of Active Devices in Netherlands, 2007 30
Figure 10:
Flowchart for Classification of Devices except Non-invasive, Invasive and
Active Devices in Netherlands, 2007 31
Figure 11: Conformity Assessment
of Class-I Medical Devices in Netherlands, 2007 32
Figure 12: Conformity
Assessment of Class-IIa Medical Devices in Netherlands, 2007 33
Figure 13:
Conformity Assessment of Class-IIb Medical Devices in Netherlands, 2007 34
Figure 14: Conformity Assessment of Class-III Medical Devices in Netherlands,
2007 35
Figure 15: Ophthalmic Devices Cross Country Comparison
(2000-2012) 38
Figure 16: Ophthalmic Devices, Netherlands, Overall
Revenues ($ mn), 2000-2012 39
Figure 17: Ophthalmic Devices Market,
Netherlands, Portfolio Analysis, 2000-2012 40
Figure 18: Ophthalmic
Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007 41
Figure 19: Ophthalmic Devices, Netherlands, Overall Revenues ($ mn),
Forecast, 2007-2012 42
Figure 20: Ophthalmic Devices, Netherlands
Company share (%), 2007 44
Figure 21: Cataract Surgery, Netherlands,
Revenue ($ mn) by Segment, Historic, 2000-2007 45
Figure 22: Cataract
Surgery, Netherlands, Revenue ($ mn) by Segment, Forecast, 2007-2012 46
Figure 23: Cataract Surgery, Netherlands, Overall Volume (Units),
Historic, 2000-2007 47
Figure 24: Cataract Surgery, Netherlands,
Overall Volume (Units), Forecast, 2007-2012 48
Figure 25: Cataract
Surgery, Netherlands, Company Share (%), 2007 51
Figure 26:
Refractive Surgery, Netherlands, Revenue ($ mn), Historic, 2000-2007 52
Figure 27: Refractive Surgery, Netherlands, Revenue ($ mn), Forecast,
2007-2012 53
Figure 28: Refractive Surgery, Netherlands, Overall
Volume (Units), Historic, 2000-2007 54
Figure 29: Refractive Surgery,
Netherlands, Overall Volume (Units), Forecast, 2007-2012 55
Figure 30:
Refractive Surgery, Netherlands, Company Share (%), 2007 58
Figure 31:
Vision Care, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2007
59
Figure 32: Vision Care, Netherlands, Revenue ($ mn) by Segment,
Forecast, 2007-2012 60
Figure 33: Vision Care, Netherlands, Overall
Volume (Units), Historic, 2000-2007 61
Figure 34: Vision Care,
Netherlands, Overall Volume (Units), Forecast, 2007-2012 62
Figure 35:
Vision Care, Netherlands, Company Share (%), 2007 65
Figure 36:
Bausch & Lomb Incorporated Value Chain Analysis 67
Figure 37: Alcon,
Inc. Value Chain Analysis 73
Figure 38: Essilor International Value
Chain Analysis 78
Figure 39: Global Markets Direct Methodology 86
|
Related Report
|
View Cart
